RadNet (NASDAQ:RDNT) Research Coverage Started at B. Riley
B. Riley started coverage on shares of RadNet (NASDAQ:RDNT – Free Report) in a report published on Friday, Marketbeat.com reports. The firm issued a buy rating and a $69.00 target price on the medical research company’s stock. Other equities research analysts also recently issued reports about the company. Wall Street Zen downgraded RadNet from a […]
